{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:25Z","timestamp":1790240545739,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms7072","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T08:39:58Z","timestamp":1422002398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":193,"title":["An IL-27\/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction"],"prefix":"10.1038","volume":"6","author":[{"given":"Chen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sakuishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Zaghouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewar J.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Rangachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Tak","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Kuchroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"BFncomms7072_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536\u2013541 (2002).","journal-title":"Nature"},{"key":"BFncomms7072_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6, 1245\u20131252 (2005).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR3","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20081398","volume":"205","author":"RB Jones","year":"2008","unstructured":"Jones, R. B. et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205, 2763\u20132779 (2008).","journal-title":"J. Exp. Med."},{"key":"BFncomms7072_CR4","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1172\/JCI43127","volume":"120","author":"RH McMahan","year":"2010","unstructured":"McMahan, R. H. et al. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120, 4546\u20134557 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFncomms7072_CR5","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin, H. T. et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl Acad. Sci. USA 107, 14733\u201314738 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms7072_CR6","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187\u20132194 (2010).","journal-title":"J. Exp. Med."},{"key":"BFncomms7072_CR7","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","volume":"117","author":"Q Zhou","year":"2011","unstructured":"Zhou, Q. et al. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 117, 4501\u20134510 (2011).","journal-title":"Blood"},{"key":"BFncomms7072_CR8","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1084\/jem.20100637","volume":"207","author":"J Fourcade","year":"2010","unstructured":"Fourcade, J. et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 207, 2175\u20132186 (2010).","journal-title":"J. Exp. Med."},{"key":"BFncomms7072_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"BFncomms7072_CR10","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1084\/jem.20061496","volume":"203","author":"C Petrovas","year":"2006","unstructured":"Petrovas, C. et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 203, 2281\u20132292 (2006).","journal-title":"J. Exp. Med."},{"key":"BFncomms7072_CR11","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nature Med. 12, 1198\u20131202 (2006).","journal-title":"Nature Med."},{"key":"BFncomms7072_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354 (2006).","journal-title":"Nature"},{"key":"BFncomms7072_CR13","first-page":"1","volume":"350","author":"C Zhu","year":"2010","unstructured":"Zhu, C., Anderson, A. C. & Kuchroo, V. K. TIM-3 and its regulatory role in immune responses. Curr. Top. Microbiol. Immunol. 350, 1\u201315 (2010).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFncomms7072_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/eji.200939842","volume":"40","author":"AC Anderson","year":"2010","unstructured":"Anderson, A. C. et al. T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur. J. Immunol. 40, 859\u2013866 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFncomms7072_CR15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ni1541","volume":"8","author":"A Awasthi","year":"2007","unstructured":"Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380\u20131389 (2007).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR16","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.4049\/jimmunol.180.5.2752","volume":"180","author":"M Batten","year":"2008","unstructured":"Batten, M. et al. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180, 2752\u20132756 (2008).","journal-title":"J. Immunol."},{"key":"BFncomms7072_CR17","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.4049\/jimmunol.170.10.4886","volume":"170","author":"A Takeda","year":"2003","unstructured":"Takeda, A. et al. Cutting edge: role of IL-27\/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170, 4886\u20134890 (2003).","journal-title":"J. Immunol."},{"key":"BFncomms7072_CR18","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/ni1540","volume":"8","author":"DC Fitzgerald","year":"2007","unstructured":"Fitzgerald, D. C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372\u20131379 (2007).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ni.2046","volume":"12","author":"C Kao","year":"2011","unstructured":"Kao, C. et al. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat. Immunol. 12, 663\u2013671 (2011).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR20","doi-asserted-by":"crossref","unstructured":"Yosef, N. et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496, 461\u2013468.","DOI":"10.1038\/nature11981"},{"key":"BFncomms7072_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/ni.2020","volume":"12","author":"Y Motomura","year":"2011","unstructured":"Motomura, Y. et al. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat. Immunol. 12, 450\u2013459 (2011).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ni794","volume":"3","author":"M Afkarian","year":"2002","unstructured":"Afkarian, M. et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549\u2013557 (2002).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.immuni.2011.11.012","volume":"35","author":"S Nakayamada","year":"2011","unstructured":"Nakayamada, S. et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35, 919\u2013931 (2011).","journal-title":"Immunity"},{"key":"BFncomms7072_CR24","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nature Med. 12, 1301\u20131309 (2006).","journal-title":"Nature Med."},{"key":"BFncomms7072_CR25","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1084\/jem.20061462","volume":"203","author":"M Ejrnaes","year":"2006","unstructured":"Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461\u20132472 (2006).","journal-title":"J. Exp. Med."},{"key":"BFncomms7072_CR26","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","volume":"113","author":"J Klibi","year":"2009","unstructured":"Klibi, J. et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113, 1957\u20131966 (2009).","journal-title":"Blood"},{"key":"BFncomms7072_CR27","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.4049\/jimmunol.0803673","volume":"182","author":"S Sehrawat","year":"2009","unstructured":"Sehrawat, S., Suryawanshi, A., Hirashima, M. & Rouse, B. T. Role of Tim-3\/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182, 3191\u20133201 (2009).","journal-title":"J. Immunol."},{"key":"BFncomms7072_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni987","volume":"4","author":"A Sanchez-Fueyo","year":"2003","unstructured":"Sanchez-Fueyo, A. et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4, 1093\u20131101 (2003).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni988","volume":"4","author":"CA Sabatos","year":"2003","unstructured":"Sabatos, C. A. et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4, 1102\u20131110 (2003).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR30","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.1128\/JVI.00639-09","volume":"83","author":"L Golden-Mason","year":"2009","unstructured":"Golden-Mason, L. et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J. Virol. 83, 9122\u20139130 (2009).","journal-title":"J. Virol."},{"key":"BFncomms7072_CR31","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI59806","volume":"122","author":"ZZ Yang","year":"2012","unstructured":"Yang, Z. Z. et al. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J. Clin. Invest. 122, 1271\u20131282 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFncomms7072_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni1375","volume":"7","author":"M Batten","year":"2006","unstructured":"Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929\u2013936 (2006).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR33","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/ard.2007.083360","volume":"67","author":"W Niedbala","year":"2008","unstructured":"Niedbala, W. et al. Interleukin 27 attenuates collagen-induced arthritis. Ann. Rheum. Dis. 67, 1474\u20131479 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFncomms7072_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/ard.2007.077537","volume":"67","author":"N Sugiyama","year":"2008","unstructured":"Sugiyama, N. et al. Amelioration of human lupus-like phenotypes in MRL\/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann. Rheum. Dis. 67, 1461\u20131467 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFncomms7072_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1074-7613(03)00300-5","volume":"19","author":"A Villarino","year":"2003","unstructured":"Villarino, A. et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19, 645\u2013655 (2003).","journal-title":"Immunity"},{"key":"BFncomms7072_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1074-7613(03)00298-X","volume":"19","author":"S Hamano","year":"2003","unstructured":"Hamano, S. et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19, 657\u2013667 (2003).","journal-title":"Immunity"},{"key":"BFncomms7072_CR37","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.4049\/jimmunol.0801162","volume":"182","author":"C Diveu","year":"2009","unstructured":"Diveu, C. et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182, 5748\u20135756 (2009).","journal-title":"J. Immunol."},{"key":"BFncomms7072_CR38","doi-asserted-by":"publisher","first-page":"15047","DOI":"10.1073\/pnas.2536517100","volume":"100","author":"S Lucas","year":"2003","unstructured":"Lucas, S., Ghilardi, N., Li, J. & de Sauvage, F. J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl Acad. Sci. USA 100, 15047\u201315052 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms7072_CR39","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.immuni.2012.03.024","volume":"36","author":"K Hirahara","year":"2012","unstructured":"Hirahara, K. et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36, 1017\u20131030 (2012).","journal-title":"Immunity"},{"key":"BFncomms7072_CR40","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.4049\/jimmunol.175.3.1686","volume":"175","author":"N Morishima","year":"2005","unstructured":"Morishima, N. et al. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 175, 1686\u20131693 (2005).","journal-title":"J. Immunol."},{"key":"BFncomms7072_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nm.2110","volume":"16","author":"RC Axtell","year":"2010","unstructured":"Axtell, R. C. et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nature Med. 16, 406\u2013412 (2010).","journal-title":"Nature Med."},{"key":"BFncomms7072_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ni.1996","volume":"12","author":"J Sun","year":"2011","unstructured":"Sun, J., Dodd, H., Moser, E. K., Sharma, R. & Braciale, T. J. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 12, 327\u2013334 (2011).","journal-title":"Nat. Immunol."},{"key":"BFncomms7072_CR43","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.4049\/jimmunol.1003888","volume":"186","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi, T. et al. NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity. J. Immunol. 186, 4649\u20134655 (2011).","journal-title":"J. Immunol."},{"key":"BFncomms7072_CR44","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/emboj.2011.111","volume":"30","author":"M Kashiwada","year":"2011","unstructured":"Kashiwada, M., Cassel, S. L., Colgan, J. D. & Rothman, P. B. NFIL3\/E4BP4 controls type 2 T helper cell cytokine expression. EMBO J. 30, 2071\u20132082 (2011).","journal-title":"EMBO J."},{"key":"BFncomms7072_CR45","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.4049\/jimmunol.177.8.5377","volume":"177","author":"T Yoshimura","year":"2006","unstructured":"Yoshimura, T. et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177, 5377\u20135385 (2006).","journal-title":"J. Immunol."}],"updated-by":[{"DOI":"10.1038\/ncomms8657","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms7072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms7072","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms7072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:17:35Z","timestamp":1672903055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms7072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,5]]}},"alternative-id":["BFncomms7072"],"URL":"https:\/\/doi.org\/10.1038\/ncomms7072","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725324746.793543522","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]},"assertion":[{"value":"26 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2015","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.K.K. and A.C.A. are paid consultants for Novartis Pharmaceuticals, which has interests in cancer immunotherapy. All other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6072"}}